pCR3.1-mGM-CSF Citations (1)

Originally described in: In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity.
Heller L, Pottinger C, Jaroszeski MJ, Gilbert R, Heller R Melanoma Res. 2000 Dec;10(6):577-83. PubMed

Articles Citing pCR3.1-mGM-CSF

Showing 1 to 1 of 1 entries

Show entries

Search table:

Articles
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, Belle JI, Lee WC, Wong WH, Fontana F, Hernandez-Aya LF, Kobayashi T, Tomasson HM, Su J, Bakewell SJ, Stewart SA, Egbulefu C, Karmakar P, Meyer MA, Veis DJ, DeNardo DG, Lanza GM, Achilefu S, Weilbaecher KN. J Clin Invest. 2021 Oct 15;131(20). pii: e145296. doi: 10.1172/JCI145296. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.